Navigation Links
CORRECTION: Star Scientific Issues Statement Correcting the Underreporting of the "Flint" CRP Human Study Results
Date:10/26/2012

GLEN ALLEN, Va., Oct. 26, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) announced today that the press release issued 10/24/2012, titled "Star Scientific Announces Successful First Look at the "Flint" CRP Human Study and Provides Updated Report on ASAP Human Thyroid Study", incorrectly stated the interim results of the "Flint" CRP study.  In the release, the Company reported: "After one month of supplementation, CRP levels dropped in 26% of the subjects with diabetes, compared with a drop in CRP levels in 12% of the general trial population of subjects who did not have diabetes." These figures reflected an understatement of the decrease in CRP levels after anatabine supplementation.  The correct figures are as follows: 11 of 18 (61%) diabetic subjects on metformin had a CRP reduction, as did 31 of 81 (38%) subjects in the general trial population not taking metformin.  Overall, 42 of 99 (42%) subjects had a decrease in CRP after only one month with anatabine supplementation. 

The anatabine used in the clinical trial is made under the Company's patented process and is the main ingredient in its Anatabloc® product, which is sold in GNC stores nationwide.

(Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO )

Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Discovery of New "Youth Pill" Revealed At International Scientific Conference
2. Presentation of Possible "Fountain of Youth" Pill Creating "Celebrity" Atmosphere at San Antonio Scientific Conference
3. Unigene To Present at the 2012 Obesity Societys 30th Annual Scientific Meeting
4. Eaton Scientific Expands Investor Relations Strategy and Launches Important New Website Content
5. Boston Scientific to Acquire BridgePoint Medical, Inc.
6. Eaton Scientific Teams Up with Renowned Womens Sexual Health Expert Dr. Jennifer R. Berman, MD and Berman Sexual Health to Advance Tropine 3 Trials and Marketing
7. Eaton Scientific Systems, Ltd. completes its Study Protocol for its Planned Clinical Trial of its Patent Pending Non-Hormonal Treatment of Hot Flashes.
8. Boston Scientific to Participate in the 2012 Morgan Stanley Global Healthcare Conference
9. Islet Sciences Appoints Dr. Kevan Herold and Dr. Morton Printz to Scientific Advisory Board
10. Eaton Scientific Enters Agreement with RoxSan Pharmacy to Provide Tropine 3 for its upcoming Clinical Trial Participants
11. Eaton Scientific Discusses Positive Anecdotal Feedback from Pharmacist Compounding Homatropine for Doctors Treating Patients Experiencing Hot Flash Symptoms in the Beverley Hills and Los Angeles Area.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... SAN DIEGO , March 30, 2015 /PRNewswire/ ... announced that Tom Cannell has joined ... for global commercialization of Contrave® /Mysimba™ (naltrexone HCl ... all aspects of Orexigen,s global commercial strategy, assuming ... After successfully leading Orexigen,s commercial effort through the ...
(Date:3/30/2015)... , March 30, 2015  New York College ... world class Intellectual Properties portfolio with U.S. Patent #8,996,098 ... policy. This patent represents a surgical instrument that allows ... as if it were in the traditional format of ... it against medical databases during surgery, thus providing the ...
(Date:3/30/2015)... , March 30, 2015 Sorrento Therapeutics, Inc. ... George K. Ng to the position of ... capacity, Mr. Ng will be responsible for all legal, ... joins the Company from BioDelivery Sciences International, Inc., where ... a member of senior management that led that company ...
Breaking Medicine Technology:Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3
(Date:3/30/2015)... March 30, 2015 Dr. Jeff Farmer now ... , The mini implant is placed into the bone, usually ... is fitted and snapped into place. For those having trouble ... implants could be the solution. Thousands of patients around the ... without any adhesives. It is all made possible by mini ...
(Date:3/30/2015)... Columbus, OH (PRWEB) March 30, 2015 ... in product liability lawsuits, notes that the number of ... federal multidistrict litigation underway in U.S. District Court, District ... established in December 2014. "According to an update released ... on March 16th, at least 493 Syngenta lawsuits are ...
(Date:3/30/2015)... New York (PRWEB) March 30, 2015 ... been filed in California Superior Court on behalf of ... heart birth defect after his mother was prescribed the ... to the March 6th filing in Alameda Superior Court, ... nausea and vomiting that she experienced in the early ...
(Date:3/30/2015)... 30, 2015 On March 11, 2015, Elle ... Away Fat,” details six new treatment options for dealing with ... one is a topical product. The other three technologies use ... Liposonix ) or freezing cold ( CoolSculpting ) to kill ... now available to us to permanently remove unwanted fat," says ...
(Date:3/30/2015)... In a recent report published by ... is championing effective drug and alcohol treatment for victims ... recover funds to stabilize the addiction treatment programs, and ... drug and alcohol addiction. Harbor Village Detox is extending ... use disorders in New Jersey, in hopes to help ...
Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3
... services rendered to Scotland children, could soon come to an ... out by ministers. // Dental practices in Scotland yield a ... number of registered NHS patients. ,There exists a ... such extra payments, says the British Dental Association (BDA). This ...
... study and found that the rates have increased among those who ... getting their children immunized with the three-in-one MMR jab in Scotland. ... level of 95% by the age of two. But there was ... due to the vaccines association with the childhood autism disease. ...
... newly developed bird flu vaccine would soon be launched ... national pharmaceutical agency //. The Prime Minister, Ferenc Gyurcsany, ... the much dreaded bird flu, last year. Vaccine trials ... results. The bird flu vaccine is claimed to confer ...
... of researchers from Warwick Medical School found that premature babies ... ,The study included 120,000 children born between 1983 and ... low birth weight and were born premature are more often ... include those that were born before 34 weeks. The findings ...
... patients at the Siteman Cancer Center are a part ... the School of Medicine's Medical Photography, Illustration and Computer ... Matters," invites patients and their families to paint a ... than 400 tiles have been painted in this manner. ...
... a local clinic now you can take a simple test ... ,Chlamydia is the most common sexually transmitted infection in the ... on to others without knowing. However, complications may occur if ... in both men and women., ,The Preventx kits are ...
Cached Medicine News:Health News:Children In Scotland Denied Access To Dental Care 2Health News:Home Chlamydia Test 2
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
QuantumPlex is a bead kit for multiple analyte-detection research applications in flow cytometry. The beads may be analyzed with any standard cytometer and do not require the use of specialized softw...
... OptiMAL® assay is a sensitive, ... that permits the detection of ... malaria; and can distinguish between ... P. vivax . In ...
Medicine Products: